COVID-19. COVID-19
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group receive medication for treatment of Covid-19 based on Fifth Edition of the Novel Corona Virus Guidelines, in addition they recieve myrtle syr
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 18-65 years old Developed mild to moderate COVID-19 based on Fifth Edition of the Novel Corona Virus Guidelines Candidate for outpatient treatment
Exclusion criteria
Exclusion criteria: Allergy to myrtle Asthma or allergy Hypertension Diabetes Pregnancy/lactation Congestive heart failure Chronic renal failure Chemotherapy Taking Corticosteroid Immune deficiency
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Temperature. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Termometer.;Cough (severity-frequency). Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Fisman Cough Severity Score.;Weakness. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Muscular pain. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Respiratory rate. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Counting the number of breaths per minute. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital admssion. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Ratio of the number of admission to total patients in each group.;Mortality. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Ratio of the number of deaths to total patients in each group. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Azimi
Kerman University of Medical Sciences
Outcome results
None listed